STROMALab Médecine régénératrice, thérapie cellulaire, cellules souches mésenchymateuses, tissu adipeux, moelle osseuse, réparation, régénération Regenerative medicine, cell therapy, mesenchymal stem cells, adipose tissue, bone marrow, repair, regeneration

E Cell France – Potency test for therapeutic cell

logo ECF

ECellFrance (www.ecellfrance.com) is a national network for adult's MSC-based therapy development. ECellFrance offers to assist both academic and industrial partners with the implementation of their pre-clinical and/or clinical programs in the emerging field of cell-based therapies. The ECellFrance network for regenerative medecine provides services covering the entire MSC-based production and development pipeline:

  • MSC production
  • Safety and potency tests for MSC
  • Immunomonitoring of MSC-treated patients
  • Pre-clinical development of MSC-based medicinal products
  • Regulatory support services
  • Clinical trial support services for phase I and phase II trials

Scientific Aim:

Currently, adult MSCs are increasingly used in clinical trial. Production, development and use of MSC-based medical products require safety and potency test. Toulouse platform STROMALab is intended to provide new quality control test in order to improve MSCs-production safety but also new potency assay in order to evaluate MSCs functional ability before therapeutic administration.

STROMALab Involvement:

STROMALab laboratory is involved in ECellFrance national network at different levels:

  • It provides its MSCs and ASCs (adipose tissue derived mesenchymal stem cell) expertise. This team is involved in the field of :
  • Safety and potency test standardization of MSC/ASC based-medicinal products.
  • Genetic stability of CSM/ASC.
  • Regenerative and immunomodulatory property of MSC and ASC.
  • Ischemic diseases
  • In collaboration with EFS, it provide expertise for the national network in:
  • GMP production of Advanced Therapy Medicinal Products (ATMP) in accordance with regulation in EFS production platform (Toulouse, Créteil, Grenoble and Besançon).
  • Manufacturing processes development.
  • Drafting of Investigational Medicinal Product Dossier (IMPD) for clinical trial.

Both team's managers are involved in steering and scientific advisory board.

 

See more

Sophie Dupuis-Coronas

PhD

sophie.coronas@inserm.fr

+33 5 61 28 37 23

 

  • BD LSR Fortessa Cell Analyzer, 5 lasers which enables the detection of up to 18 colors simultaneously.
  • BD Canto II Cell Analyzer, 8 colors.
  • BD FACSAria Fusion Cell Sorter, 4 lasers.
  • Perkin Elmer Operetta High Content Screening Systems.
  • Amnis ImageStreamX Mark II Imaging Flow Cytometer.

 

 

STROMALAB

CHU TOULOUSE – HÔPITAL DE RANGUEIL

Bât L1, 2ème étage

1 avenue Jean Poulhès – BP 84225

31432 TOULOUSE CEDEX 4

Phone : +33 5 61 28 37 21

Contact us

Actuality

Pr. Toni Vidal-Puig – University of Cambridge (UK)

20 April 2017 |  

"Adipose tissue expandability, lipotoxicity and the metabolic syndrome" 28/04/17 at 2h00 pm Salle Hervé Paris, I2MC, CHU Rangueil, 31432 Toulouse


Pr. Philippe Collas (Institute of Basic Medical Sciences – Norway)

17 January 2017 |  

"A dynamic chromatin architecture during differentiation of adipose tissue progenitors: data and models"  24/02/2017 at 11h am Salle Hervé Paris, I2MC,...


Abdel Naji (Université de Kochi, Japon)

7 October 2016 |  

" Rôle des CSM dans les différentes morts cellulaires régulées : intérêts en médecine régénérative " MERCREDI 19 OCTOBRE À 10H00...

See all